Emergent to sell US sterile manufacturing facility to Bora

Emergent BioSolutions has agreed to divest its sterile manufacturing facility in Baltimore-Camden, Maryland, US to Bora Pharmaceuticals for $30m. A part …

Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease

Johnson & Johnson (J&J) has submitted a supplemental biologics licence application (sBLA) seeking approval from the US Food and Drug …

Sanofi and Biovac partner to produce polio vaccines in Africa

Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking …

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex (fulvestrant) in the European Union (EU) for the treatment …

Will WHO’s new guidance spur hepatitis B immunisation?

Despite vaccine developments signalling advancements in the diagnosis, prevention and treatment of hepatitis B, the World Health Organization’s (WHO) 2024 …